PMID- 35351331
OWN - NLM
STAT- MEDLINE
DCOM- 20240914
LR  - 20240914
IS  - 1873-4588 (Electronic)
IS  - 0892-1997 (Linking)
VI  - 38
IP  - 5
DP  - 2024 Sep
TI  - Anxiety and Depression in Patients With Idiopathic Subglottic Stenosis.
PG  - 1165-1169
LID - S0892-1997(22)00059-5 [pii]
LID - 10.1016/j.jvoice.2022.02.020 [doi]
AB  - OBJECTIVES: To characterize the presence and severity of anxiety and depression 
      in patients with symptomatic idiopathic subglottic stenosis (ISGS). To determine 
      the relationship between dyspnea severity and anxiety and depression symptom 
      severity. METHODS: Patients diagnosed with idiopathic subglottic stenosis and 
      treated at Mayo Clinic Florida or Mayo Clinic Arizona retrospectively completed 
      the PROMIS Depression, PROMIS Anxiety, PROMIS Dyspnea Functional Limitations, and 
      Dyspnea Index questionnaires. Patients with dyspnea and without idiopathic 
      subglottic stenosis were also asked to complete the questionnaires as a control 
      group. RESULTS: This explorative retrospective study includes 44 control patients 
      and 46 ISGS patients. Unadjusted and adjusted group comparisons found no 
      statistically significant difference in dyspnea index, depression, anxiety, nor 
      dyspnea functional limitation scores. Relationships between dyspnea severity and 
      anxiety and depression severity were significant and persistent in both groups. 
      Anxiety and depression were positively correlated (r = 0.66). Dyspnea severity 
      positively correlate with both anxiety and depression (anxiety r = 0.49, 
      depression r = 0.32). CONCLUSIONS: Patients with symptomatic idiopathic 
      subglottic stenosis are not at an increased risk of having anxiety and depression 
      when compared to other dyspneic patients. As dyspnea severity worsens, patients 
      are more likely to experience anxiety and depression. These findings support the 
      prior literature and suggest the presence of dyspnea may warrant appropriate 
      psychological screening and treatment to optimize dyspneic patients' quality of 
      life and symptom improvement.
CI  - Published by Elsevier Inc.
FAU - Case, Hannah F
AU  - Case HF
AD  - Mayo Clinic Alix School of Medicine, Mayo Clinic, Jacksonville, Florida.
FAU - Lott, David G
AU  - Lott DG
AD  - Mayo Clinic Department of Laryngology, Mayo Clinic Arizona, Phoenix, Arizona.
FAU - DO, Amy L Rutt
AU  - DO ALR
AD  - Mayo Clinic Department of Laryngology, Mayo Clinic Florida, Jacksonville, 
      Florida. Electronic address: rutt.amy@mayo.edu.
LA  - eng
PT  - Journal Article
DEP - 20220326
PL  - United States
TA  - J Voice
JT  - Journal of voice : official journal of the Voice Foundation
JID - 8712262
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - *Laryngostenosis/diagnosis/physiopathology/psychology
MH  - Middle Aged
MH  - Retrospective Studies
MH  - *Anxiety/diagnosis/psychology
MH  - *Depression/diagnosis/psychology
MH  - *Severity of Illness Index
MH  - *Dyspnea/physiopathology/diagnosis/psychology
MH  - Adult
MH  - Aged
MH  - Surveys and Questionnaires
MH  - Risk Factors
MH  - Quality of Life
MH  - Florida
OTO - NOTNLM
OT  - Anxiety
OT  - Depression
OT  - Dyspnea
OT  - Idiopathic subglottic stenosis
EDAT- 2022/03/31 06:00
MHDA- 2024/09/15 14:09
CRDT- 2022/03/30 05:38
PHST- 2022/01/13 00:00 [received]
PHST- 2022/02/18 00:00 [revised]
PHST- 2022/02/20 00:00 [accepted]
PHST- 2024/09/15 14:09 [medline]
PHST- 2022/03/31 06:00 [pubmed]
PHST- 2022/03/30 05:38 [entrez]
AID - S0892-1997(22)00059-5 [pii]
AID - 10.1016/j.jvoice.2022.02.020 [doi]
PST - ppublish
SO  - J Voice. 2024 Sep;38(5):1165-1169. doi: 10.1016/j.jvoice.2022.02.020. Epub 2022 
      Mar 26.